Desert Medical Group Inc.

Palm Springs, California 92262

0 studies enrolling now · 6 studies all time

What they study most

Colorectal Cancer, Diabetes Mellitus, Type 2, Hepatitis C, Hepatitis C, Genotype 1, Hypertension, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed
• A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes — Completed
• Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold — Completed
• Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus — Completed
• Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients — Stopped early
• Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin — Completed